Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.

Silkenstedt, Elisabeth; Linton, Kim; Dreyling, Martin

Silkenstedt, Elisabeth; Linton, Kim; Dreyling, Martin.

Affiliation

Silkenstedt E; Department of Medicine III, LMU Hospital, Munich, Germany.
Linton K; Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
Dreyling M; Department of Medicine III, LMU Hospital, Munich, Germany.

Br J Haematol ; 195(2): 162-173, 2021 10.

Article in En | MEDLINE | ID: mdl-33783838

Subject(s)

Lymphoma, Mantle-Cell/genetics; Lymphoma, Mantle-Cell/pathology; Molecular Biology/methods; Molecular Targeted Therapy/methods; Aged; Female; High-Throughput Nucleotide Sequencing/methods; Humans; Immunoglobulin Heavy Chains/genetics; Lymphoma, Mantle-Cell/diagnosis; Lymphoma, Mantle-Cell/metabolism; Male; Molecular Biology/statistics & numerical data; Neoplasm Staging/methods; Prognosis; Risk Assessment; SOXC Transcription Factors; Severity of Illness Index; Survival Rate/trends

Key words

Mantle cell lymphoma; genetics; pathogenesis; prognostication; therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Molecular Targeted Therapy / Molecular Biology Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Br J Haematol Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google